Clinical trial

Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

NCT00087516

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-06-01

PhasePHASE3

Study timeline

Study start (unknown)2004-06-01Date precision: month

Registry last updated2015-07-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Sitagliptin (MK0431)DRUG

SitagliptinDRUG · verified · RxNorm: sitagliptin

PlaceboDRUG

Metformin - RescueDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00087516 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.